Skip to main content
Quest Diagnostics

Prognostic Melanoma Molecular Testing to Inform Better Patient Care

On-demand webinar: 

Prognostic Melanoma Molecular Testing to Inform Better Patient Care

 

To watch the webinar please click HERE.

Short Description:

A clinical conversation about how prognostic molecular testing such as MelaNodal™ Predict can help assesses a patient's tumor genomics alongside clinicopathologic features to identify their risk level for sentinel lymph node (SLN) metastasis. This insight can objectively qualify which patients are at a low risk of metastasis and may avoid undergoing sentinel lymph node biopsy (SNLB). The video features, Dr Carlos Nousari of Dermpath Diagnostics, Dr Alexander Meves of Mayo Clinic College of Medicene, and Liz Holland, RN, BSN, MFA of Quest Diagnostics.

 

Presenters:

Dr Carlos Nousari, Dermpath Diagnostics

Dr Alexander Meves, Mayo Clinic College of Medicine

Liz Holland, RN, BSN, MFA, Quest Diagnostics.

 

Time of talk:  44 minutes

 

Posted as on-demand webinar: December 19, 2024

 

 

Disclosure: The views and opinions are those of the presenter. The content was current as of the time of recording in 2024.

Date:
Dec 19, 2024
Location:
This is a virtual on-demand webinar
Speaker(s):
 

Dr Carlos Nousari, Dermpath Diagnostics

Dr Alexander Meves, Mayo Clinic College of Medicene

Liz Holland, RN, BSN, MFA, Quest Diagnostics.

Related content

Test FAQ
MelaNodal Predict
Publication
Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study
Audio Podcast
Molecular Expression Through the Eyes of the Pathologist and Oncologist
Audio Podcast
Optimize Oncology Care with Clinical Pathways

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.